Henry Schein, Inc. (NASDAQ:HSIC) Short Interest Update

Henry Schein, Inc. (NASDAQ:HSIC) was the recipient of a significant increase in short interest during the month of March. As of March 13th, there was short interest totaling 5,374,661 shares, an increase of 28.9% from the February 26th total of 4,168,764 shares. Based on an average trading volume of 1,379,464 shares, the days-to-cover ratio is presently 3.9 days. Currently, 4.7% of the company’s shares are sold short.

Analyst Ratings Changes

A number of analysts have issued reports on the company. Morgan Stanley raised their price target on Henry Schein from $58.00 to $61.00 and gave the stock an “underweight” rating in a research note on Wednesday, February 25th. Barrington Research set a $97.00 price objective on shares of Henry Schein and gave the company an “outperform” rating in a research note on Wednesday, February 25th. Barclays initiated coverage on shares of Henry Schein in a research report on Monday, December 8th. They issued an “overweight” rating and a $86.00 target price on the stock. Leerink Partners restated a “market perform” rating on shares of Henry Schein in a report on Monday, March 9th. Finally, Robert W. Baird set a $100.00 price target on shares of Henry Schein and gave the stock an “outperform” rating in a research report on Monday, February 23rd. Six analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $85.58.

Insider Transactions at Henry Schein

In other Henry Schein news, EVP Mark E. Mlotek sold 5,925 shares of the business’s stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $80.80, for a total value of $478,740.00. Following the completion of the transaction, the executive vice president directly owned 80,554 shares in the company, valued at approximately $6,508,763.20. The trade was a 6.85% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Stanley M. Bergman sold 43,812 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $81.31, for a total value of $3,562,353.72. Following the transaction, the chief executive officer directly owned 383,803 shares in the company, valued at approximately $31,207,021.93. This represents a 10.25% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 105,911 shares of company stock worth $8,574,982 in the last three months. 1.08% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Henry Schein

Several large investors have recently made changes to their positions in HSIC. CYBER HORNET ETFs LLC purchased a new stake in Henry Schein during the 2nd quarter worth $25,000. MUFG Securities EMEA plc purchased a new position in Henry Schein in the 2nd quarter valued at about $27,000. Flagship Harbor Advisors LLC purchased a new position in Henry Schein in the 4th quarter valued at about $30,000. Federated Hermes Inc. acquired a new stake in shares of Henry Schein during the fourth quarter valued at about $32,000. Finally, Los Angeles Capital Management LLC acquired a new stake in shares of Henry Schein during the fourth quarter valued at about $37,000. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Trading Down 2.2%

HSIC stock traded down $1.61 during trading on Friday, reaching $72.10. 982,731 shares of the stock traded hands, compared to its average volume of 1,305,034. The firm has a market capitalization of $8.27 billion, a PE ratio of 22.05, a P/E/G ratio of 2.13 and a beta of 0.88. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.38 and a quick ratio of 0.76. The business’s 50 day moving average price is $77.37 and its 200-day moving average price is $73.22. Henry Schein has a 52-week low of $60.56 and a 52-week high of $89.29.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, February 24th. The company reported $1.34 EPS for the quarter, topping analysts’ consensus estimates of $1.30 by $0.04. Henry Schein had a return on equity of 15.16% and a net margin of 3.02%.The company had revenue of $3.44 billion for the quarter, compared to the consensus estimate of $3.34 billion. During the same period last year, the business posted $1.19 EPS. The company’s quarterly revenue was up 7.7% compared to the same quarter last year. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. As a group, sell-side analysts forecast that Henry Schein will post 4.74 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.